How Are Multifocal, Multicentric Breast Cancers Diagnosed?
At a Glance
Doctors evaluate cancer in multiple breast spots or both breasts with mammograms and targeted ultrasound, sometimes breast MRI, and biopsy of suspicious areas that could change treatment. Each tumor may be benign or have different features, so separate biopsy results guide care.
In this answer
4 sections
Doctors check for cancer in multiple spots or in both breasts using standard mammograms and targeted ultrasounds, and they may selectively use a breast MRI [1]. If imaging shows additional suspicious areas that could change your treatment, doctors will often recommend an image-guided core biopsy for each distinct spot before making a surgical plan [2]. Because an extra spot could be benign or have a different cancer profile, getting accurate biopsy results ensures your treatment is tailored exactly to your disease [3].
If you have just been diagnosed with breast cancer in the upper-outer quadrant, it is normal to feel anxious if imaging reveals other suspicious areas. Importantly, having multiple tumors in one breast, or even tumors in both breasts, does not automatically mean the cancer has “spread” to other parts of your body (metastatic or stage IV disease). Often, tumors in the opposite breast are separate, new primary cancers rather than metastases [4].
Understanding the Terminology
If your care team finds more than one tumor, they will use specific terms to describe the extent of the cancer. However, definitions can vary slightly between clinics (e.g., depending on the distance between tumors), so your specific pathology report matters more than the label [5].
- Multifocal breast cancer: Multiple tumor foci are located within the same “quadrant” (section) of the breast [5]. For example, having two separate tumors in the upper-outer quadrant is considered multifocal.
- Multicentric breast cancer: Multiple tumors are located in different quadrants of the same breast [5].
- Bilateral breast cancer: Cancer is present in both the left and the right breast [4]. If both are diagnosed around the same time, it is called “synchronous” bilateral breast cancer.
How Doctors Check for Multiple Spots
To determine the true extent of the cancer locally, your medical team relies on a few complementary imaging tools:
- Mammography and Ultrasound: These are standard first-line tools. A mammogram provides a broad view, while an ultrasound is excellent for looking closely at specific areas and safely guiding biopsies [1].
- Breast MRI: A contrast-enhanced MRI is highly sensitive and can map the extent of cancer by finding tumors that were invisible on a mammogram [6]. However, an MRI is not automatically required for everyone. Its use depends on your breast density, tumor type, genetic risk, or if conventional imaging is unclear. Because an MRI can sometimes produce “false positives” (highlighting areas that look suspicious but are not cancer), a mastectomy should generally not be planned based on MRI images alone [2]. Findings that would change your surgery should be confirmed with a biopsy when feasible [2].
Why Distinct Spots May Need Their Own Biopsy
Not every single abnormal spot on an MRI requires a biopsy—some may just be followed with imaging. But if a distinct suspicious lesion could change your surgical or systemic treatment plan, your doctor will likely order an image-guided core needle biopsy [7].
Core biopsies are usually done with local anesthetic. You may feel pressure during the procedure and experience some bruising afterward. If a spot is only visible on an MRI, an MRI-guided biopsy requires a specific setup, which your care team will explain in advance.
Biopsying distinct spots is vital for several reasons:
- Confirming Cancer: Extra spots might be benign (non-cancerous). Confirming this prevents you from undergoing a more extensive surgery than necessary [8].
- Checking Receptors and Grade: Breast cancers are categorized by estrogen receptors (ER), progesterone receptors (PR), HER2 status, and histologic grade (how abnormal the cells look under a microscope). A second tumor can sometimes have a completely different receptor status or grade than the first tumor [3].
- Tailoring Treatment: If a second tumor has different characteristics, your medical oncologist may adjust your systemic treatments (like adding a targeted therapy aimed specifically at HER2-positive cells) to ensure all of the cancer is treated effectively [9].
How Disease Extent Affects Your Options
Finding out that you have multifocal, multicentric, or bilateral breast cancer will influence your treatment, but your medical team will help you evaluate all available options.
Surgery: Lumpectomy vs. Mastectomy
Having multiple tumors does not automatically mean you need a mastectomy (complete breast removal). Many patients with multifocal or multicentric breast cancer are still candidates for a lumpectomy (breast-conserving surgery) followed by radiation [10].
A lumpectomy is possible if the surgeon can safely remove all the tumors with clear margins (no cancer cells at the edge of the removed tissue) while leaving an acceptable cosmetic result [10]. This depends on the exact size and location of the tumors, your breast size, and whether oncoplastic surgery (combining cancer removal with plastic surgery techniques) is an option for you [11]. For bilateral cancer, each breast is evaluated individually; you might have a lumpectomy on one side and a mastectomy on the other [12].
Treatment Before Surgery (Neoadjuvant Therapy)
If you have multiple tumors, your doctor might discuss neoadjuvant therapy (chemotherapy, targeted therapy, or endocrine therapy given before surgery). This decision is driven primarily by tumor biology (such as being HER2-positive or triple-negative) and lymph node involvement, rather than just the number of tumors [13]. In some cases, neoadjuvant therapy can shrink the tumors enough to make a lumpectomy possible for someone who originally might have needed a mastectomy [14].
Genetic Risk Factors
Your doctor may recommend a genetics consultation based on your age, family history, tumor subtype, or having bilateral disease. If testing reveals a high-risk gene mutation (such as a BRCA1 or BRCA2 mutation), you have a higher risk of developing new breast cancers in the future. In this scenario, doctors will discuss risk-reducing options, which may include a bilateral mastectomy to lower the risk of future cancers [15]. This is a discussion about reducing future risk, not an absolute requirement for treating your current tumors.
Common questions in this guide
What is the difference between multifocal, multicentric, and bilateral breast cancer?
Does cancer in both breasts mean that it has spread?
Which tests are used to find breast cancer in more than one spot?
Does every suspicious spot on a breast MRI need a biopsy?
Why might each breast tumor need its own biopsy?
Can I still have a lumpectomy if I have multiple breast tumors?
Should someone with bilateral or multifocal breast cancer have genetic testing?
Related questions
Show more
Get notified when new evidence is published on female breast upper-outer quadrant cancer.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (15)
- 1
Magnetic Resonance Imaging in the Pre-Surgical Staging of Breast Cancer: Our Experience.
Rabasco P, Caivano R, Dinardo G, et al.
Cancer investigation 2017; (35(1)):43-50 doi:10.1080/07357907.2016.1251943.
PMID: 27901596 - 2
A comparative analysis of MRI findings versus final pathology in multicentric breast cancer patients at King Abdulaziz Medical City, Jeddah.
Alotaibi MF, Alghamdi AS, Alharbi NM, et al.
Frontiers in surgery 2026; (13()):1877150 doi:10.3389/fsurg.2026.1877150.
PMID: 42582331 - 3
Multicentric Cancer Detected at Breast MR Imaging and Not at Mammography: Important or Not?
Iacconi C, Galman L, Zheng J, et al.
Radiology 2016; (279(2)):378-84 doi:10.1148/radiol.2015150796.
PMID: 26605912 - 4
Synchronous Bilateral Breast Cancers.
Padmanabhan N, Subramanyan A, Radhakrishna S
Journal of clinical and diagnostic research : JCDR 2015; (9(9)):XC05-XC08 doi:10.7860/JCDR/2015/14880.6511.
PMID: 26500995 - 5
The effect of multifocal and multicentric tumours on local recurrence and survival outcomes in breast cancer.
Ozturk A, Ilgun S, Ucuncu M, et al.
Journal of B.U.ON. : official journal of the Balkan Union of Oncology 2021; (26(1)):196-203.
PMID: 33721452 - 6
Advancing preoperative staging in early breast cancer: A comparative analysis of imaging modalities.
Mattar A, Bitencourt A, Dwek FFM, et al.
Current problems in diagnostic radiology 2026; (55(5)):703-709 doi:10.1067/j.cpradiol.2025.08.014.
PMID: 40877065 - 7
Fine-needle versus core-needle biopsy - which one to choose in preoperative assessment of focal lesions in the breasts? Literature review.
Łukasiewicz E, Ziemiecka A, Jakubowski W, et al.
Journal of ultrasonography 2017; (17(71)):267-274 doi:10.15557/JoU.2017.0039.
PMID: 29375902 - 8
Role of Image-Guided Biopsy in Nonpalpable Breast Lesions: A Study in the Sub-Himalayan Region of North India.
Singh SP, Thakur CS, Makhaik S, et al.
South Asian journal of cancer 2025; (14(1)):53-61 doi:10.1055/s-0044-1792007.
PMID: 40124146 - 9
Multicentric Breast Cancer of the Axillary and Pectoral Breasts: A Case Report and Literature Review.
Kim H, Ko EY, Han BK, et al.
Journal of breast cancer 2022; (25(5)):436-442 doi:10.4048/jbc.2022.25.e33.
PMID: 35914750 - 10
Is Breast Conserving Surgery Oncologically Safe for Patients With Multiple Ipsilateral Breast Cancers? A Systematic Review and Meta-analysis.
Althawadi R, Albuainain RY, Ali NF, et al.
Clinical breast cancer 2026; (26(8)):49-56 doi:10.1016/j.clbc.2026.06.010.
PMID: 42447524 - 11
Expanding the Boundaries of Breast Conservation: Oncoplastic Surgery in Multifocal and Multicentric Breast Cancer.
Sağdıç MF, Kültüroğlu MO, Tunç E, Doğan L
Breast care (Basel, Switzerland) 2026; doi:10.1159/000552575.
PMID: 42459981 - 12
Effect of breast-conserving surgery plus radiotherapy versus mastectomy on breast cancer-specific survival for early-stage contralateral breast cancer.
Qian C, Liang Y, Yang M, et al.
Gland surgery 2021; (10(10)):2978-2996 doi:10.21037/gs-21-413.
PMID: 34804885 - 13
Conservative surgery after neoadjuvant chemotherapy in patients with operable breast cancer.
Franceschini G, Di Leone A, Natale M, et al.
Annali italiani di chirurgia 2018; (89()):290.
PMID: 30352955 - 14
Predictors of Residual Tumor in Breast-Conserving Therapy.
Rath MG, Uhlmann L, Heil J, et al.
Annals of surgical oncology 2015; (22 Suppl 3()):S451-8 doi:10.1245/s10434-015-4736-4.
PMID: 26224405 - 15
Management of Hereditary Breast Cancer: American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology Guideline.
Tung NM, Boughey JC, Pierce LJ, et al.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2020; (38(18)):2080-2106 doi:10.1200/JCO.20.00299.
PMID: 32243226
This page is for informational purposes only and does not constitute medical advice. Your breast surgeon, radiologist, and oncologist can explain what your imaging and biopsy results mean for your treatment.